Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)
China flag China · Delayed Price · Currency is CNY
39.38
-0.67 (-1.67%)
Aug 14, 2026, 3:00 PM CST

SHA:600211 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,9782,3271,6481,8601,140764.41
Trading Asset Securities
762.181,123976.62515.34792.49537.87
Cash & Short-Term Investments
3,7413,4502,6252,3751,9321,302
Cash Growth
23.58%31.44%10.51%22.92%48.38%66.22%
Accounts Receivable
681.27917.49732.82856.71625.68632.32
Other Receivables
204.5417.4411.8511.8212.6312.83
Receivables
885.81934.93744.67868.52638.31645.15
Inventory
194.86181.27134.19111.4399.95137.32
Prepaid Expenses
-0.070.310.011.5-
Other Current Assets
74.3770.8965.9147.7740.0497.16
Total Current Assets
4,8964,6373,5703,4032,7122,182
Property, Plant & Equipment
633.38655.35669.85600.33551.38764.54
Long-Term Investments
382.81425.5132.94116.62129.75130.25
Goodwill
81.6884.018.888.888.888.88
Other Intangible Assets
274.72300.78184.09202.46416.48411.66
Long-Term Deferred Tax Assets
139.16132.52151.05115.4871.3467.16
Long-Term Deferred Charges
4.95.622.631.932.7947.69
Other Long-Term Assets
27.2226.327.99138.79206.96190.57
Total Assets
6,4406,2674,7474,5874,1003,803
Accounts Payable
50.5231.913.55.5114.3713.22
Accrued Expenses
119.87587.08377.65530.39412.7398.67
Short-Term Debt
1,110840.34272.17499.99486.1534.66
Current Portion of Leases
-0.850.920.8812.13
Current Income Taxes Payable
-29.0325.545.3127.1322.13
Current Unearned Revenue
6.22.954.919.845.343.29
Other Current Liabilities
415.89147.9771.9292.5679.56135.56
Total Current Liabilities
1,7031,640766.571,1841,0261,110
Long-Term Debt
20.01-----
Long-Term Leases
0.060.150.31.131.141.86
Long-Term Unearned Revenue
26.9728.1127.3625.8527.5330.5
Long-Term Deferred Tax Liabilities
24.8225.4612.2914.0115.61
Other Long-Term Liabilities
440.83436.06----
Total Liabilities
2,2162,130795.231,2141,0691,158
Common Stock
322.32322.32322.32247.94247.94247.94
Additional Paid-In Capital
739.45752.21,1881,2631,2661,265
Retained Earnings
2,9942,6642,3301,7731,4551,169
Comprehensive Income & Other
35.7959.5177.5761.2142.98-51.42
Total Common Equity
3,9133,7983,9183,3453,0122,630
Minority Interest
310.48339.0534.2929.0319.0314.66
Shareholders' Equity
4,2244,1373,9523,3743,0312,645
Total Liabilities & Equity
6,4406,2674,7474,5874,1003,803
Total Debt
1,130841.34273.39501.99488.25538.65
Net Cash (Debt)
2,6102,6092,3511,8731,444763.63
Net Cash Growth
11.85%10.95%25.54%29.71%89.11%-1.22%
Net Cash Per Share
8.158.097.295.804.482.36
Filing Date Shares Outstanding
315.42322.32322.32322.32322.32322.32
Total Common Shares Outstanding
315.42322.32322.32322.32322.32322.32
Working Capital
3,1932,9972,8032,2181,6861,072
Book Value Per Share
12.4111.7812.1610.389.348.16
Tangible Book Value
3,5573,4143,7253,1332,5862,210
Tangible Book Value Per Share
11.2810.5911.569.728.026.86
Buildings
-535.52530.79462.4389.99439.89
Machinery
-309.36279.08446.34139.22159.08
Construction In Progress
-39.5365.0660.71153.6272.13